Prognostic impact and risk factors of cancer-associated thrombosis events in stage-IV cancer patients treated with immune checkpoint inhibitors - Kewan, T; Ko, T; Flores, M; Sallam, Y; Haddad, A; Daw, H (Eur J Haematol, 2021)